Kannalife Sciences featured by Sports Illustrated

by adminTorusBrand | Jul 14, 2016 | Kannalife Sciences, Media Coverage

Medical Marijuana, Inc. investment company Kannalife Sciences was featured by Sports Illustrated on SI.com, in an article entitled, “How cannabis is helping one company research treatment of CTE”. Read the article on SI.com here.

FOX News Radio Interviews CEO Dr. Stuart Titus and Kannalife Sciences’ Thoma Kikis

by adminTorusBrand | Jun 24, 2016 | Company News, Kannalife Sciences, Media Coverage

Medical Marijuana, Inc. and its subsidiary Kannalife™ Sciences received attention in a major media outlet this week when Medical Marijuana, Inc. CEO Dr. Stuart Titus and Kannalife™ Sciences’s Thoma Kikis were interviewed for Fox News Radio. Listen to the interview...

Medical Marijuana, Inc. CEO to Speak on Nutritional and Therapuetic Benefits of Hemp at 3rd Annual Cannabis World Congress and Business Expo

by adminTorusBrand | Jun 9, 2016 | Company News, Kannalife Sciences, Press Releases

RSHO Advocate Penny Howard to Share Story on How Her Fight to Save Daughter Harper Helped Legalize New Markets and Change Lives in Latin America SAN DIEGO, CA – June 9, 2016 – Medical Marijuana, Inc. (OTC: MJNA) today announced that at the 3rd Annual Cannabis World...

Medical Marijuana, Inc. Announces Its Cannabis Drug Research and Drug Development Pipeline Update

by adminTorusBrand | Apr 20, 2016 | Axim Biotechnologies, Company News, Kannalife Sciences, Press Releases

MJNA’s Investments Support Development of New Cannabis-Based Medications and Delivery Methods; Developments Further the Reintroduction of Cannabis Medications Globally SAN DIEGO, CA — April 20, 2016 — Medical Marijuana, Inc. (OTC: MJNA) is pleased to announce...

Medical Marijuana, Inc. Portfolio Investment Company, Kannalife Sciences, Inc. Notified of DEA Clearance for Import of High-Purity, Pharmaceutical-Grade Cannabidiol (CBD)

by adminTorusBrand | Mar 1, 2016 | Company News, Kannalife Sciences

U.S. Phyto-Medical Company Clears Regulatory Hurdle in Its Ongoing Feasibility Study With Catalent Pharma Solutions for the Development of a Novel Cannabinoid Therapeutic Agent to Treat HE and CTE SAN DIEGO, March 01, 2016 (GLOBE NEWSWIRE) — Medical Marijuana, Inc....

Kannalife Sciences, Inc.’s New Cannabis-Derived Compound KLS-13019 Covered by Reuters, Kannalife Explores IPO This Year

by adminTorusBrand | Feb 26, 2016 | Company News, Kannalife Sciences

Reuters Reports That Kannalife is Considering an Initial Public Offering This Year to Fund Development of a Cannabis-Based Treatment for a Brain Disorder That Affects 200,000 Americans SAN DIEGO, Feb. 26, 2016 (GLOBE NEWSWIRE) — Medical Marijuana, Inc. (OTC Pink:MJNA)...